New Drug

From the United Leukodystrophy Foundation.

news.northwestern.edu/stori...

Developed for cancer, but promises to treat neurological disease-a-plenty.

"If the spherical nucleic acids cross the barrier and localize in the brain, the implications go beyond glioblastoma,” Mirkin said. “This would give us the ability to target diseases of the brain by targeting pathways that we know are associated with different diseases, including Huntington’s, Parkinson’s and Alzheimer’s diseases.”

oldestnewest

    You may also like...